IPHASE Products
|
Product Name |
Specification |
|
IPHASE Human Aqueous Fluid,Male |
Customize |
|
IPHASE Monkey(Cynomolgus) Aqueous Fluid,Male |
1mL |
|
IPHASE Rabbit(New Zealand White) Aqueous Fluid,Male |
1mL |
|
IPHASE Rabbit(New Zealand White) Aqueous Fluid,Female |
1mL |
|
IPHASE Rabbit(New Zealand White) Aqueous Fluid, Mixed Gender |
1mL |
|
IPHASE Rat(Sprague-Dawley) Aqueous Fluid,Male |
Customize |
|
IPHASE Rat(Sprague-Dawley) Aqueous Fluid,Female |
Customize |
|
IPHASE Minipig(Bama) Aqueous Fluid,Male |
1mL |
|
IPHASE Human Vitreous Humor,Male |
Customize |
|
IPHASE Monkey(Cynomolgus) Vitreous Humor,Male |
1mL |
|
IPHASE Monkey(Cynomolgus) Vitreous Humor,Female |
1mL |
|
IPHASE Rabbit(New Zealand White) Vitreous Humor,Male |
1mL |
|
IPHASE Rabbit(New Zealand White) Vitreous Humor,Female |
1mL |
|
IPHASE Rat(Sprague-Dawley)Vitreous Humor,Male |
Customize |
|
IPHASE Rat(Sprague-Dawley)Vitreous Humor,Female |
Customize |
|
IPHASE Artificial Aqueous Fluid |
50mL |
|
IPHASE Artificial Vitreous Humor |
50mL |
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is a powerful analytical technique that combines the separation capabilities of liquid chromatography with the mass analysis capabilities of tandem mass spectrometry. In LC-MS/MS, a sample mixture is first separated by liquid chromatography, where components interact differently with a stationary phase and a mobile phase, leading to their separation as they pass through the column. The separated components are then ionized and analyzed by tandem mass spectrometry, which fragments ions into product ions for detailed structural analysis.
Applications of LC-MS/MS in Bioanalysis
Bioanalysis involves the measurement of drug concentrations, metabolites, and other biological compounds within biological samples, such as blood, plasma, urine, and other biofluids. LC-MS/MS is particularly well-suited for these applications due to its high sensitivity and ability to detect low concentrations of target analytes within complex biological matrices.
LC-MS/MS technology for the analysis of biological samples detects both exogenous and endogenous substances. The researchers simulated actual samples by adding the substance to be measured to a blank matrix to formulate a quantitative standard curve sample and a quality control sample. The concentration of the substance to be measured in a biological sample is quantified by a standard curve.
Endogenous substances are substances that occur naturally in the body. Endogenous substance-related drugs have become an important direction for new drug development in recent years. Along with the birth of a large number of drugs with endogenous substances, the bioanalysis of drugs with endogenous substances has become more and more important. However, at present, the validation of biological sample analysis methods by FDA and other domestic and foreign drug review organizations mainly focuses on exogenous substances, including precision, accuracy, matrix effect, recovery rate, and stability. Since the detection of endogenous substances leads to problems in the detection results due to its own effect when obtaining blank matrix to simulate the actual sample, the emergence of alternative blank biological matrix (artificial blank biological matrix) solves this problem.
Table 1: Description of Selectivity in the Industry's Mainstream Bioanalytical Methodology Validation Guidelines
|
|
EMA BMV |
FDA BMV |
ICH M10 BMV Guideline |
Pharmacopoeia of the people's Republic of China 2020 Edition |
|
Small Molecule |
Selectivity should be proved using a least 6 individual sources of the appropriate blank matrix, which are individually analyzed and evaluated for interference. |
The sponsor should analyze blank samples of the appropriate biological matrix (e.g.plasma)from at least six (for CCs) individual sources. |
Selectivity is evaluated using blank samples (matrix samples processed without addition of an analyte or IS) obtained from at least 6 individual sources/lots non-haemolysed and non-lipaemic). Selectivity should be evaluated in lipaemic samples and haemoly sed samples. |
Selectivity should be demonstrated using suitable blank substrates from at least 6 subjects (animal blank matrix can be mixed in different batches) |
|
Macromolecule |
Selectivity is tested by spiking at least 10 sources of sample matrix at or near the LLOO. |
The sponsor should analyze blank samples of the appropriate biological matrix (e.g.plasma)from at least ten (for LBAs) individual sources. |
Selectivity is evaluated using blank samples obtained from at least 10 individual sources and by spiking the individua. blank matrices at the LLOO and at the high OC level. Selectivity should be evaluated in lipaemic samples and haemolysed samples. |
Selectivity should be examined by adding analytes at the lower and upper quantitative limit levels to matrices from at least 10 different sources, and matrices to which analytes are not added should also be measured at the same time. |
Analytical Method Development and Analytical Method Validation
In bioanalysis, ensuring the reliability and reproducibility of analytical results is paramount. This requires the rigorous development and validation of analytical methods.
Analytical Method Development involves the creation of optimized procedures for detecting and quantifying analytes of interest. This includes selecting the appropriate chromatographic conditions (e.g., stationary phase, mobile phase, flow rate) and MS parameters (e.g., ionization technique, collision energy) to achieve optimal sensitivity, resolution, and selectivity. Additionally, the method must be capable of accurately quantifying analytes in the presence of complex and variable biological matrices, which are often made up of proteins, lipids, and other compounds that may interfere with analysis.
Once a method is developed, it must undergo Analytical Method Validation to ensure that it meets predefined performance criteria. This validation process is necessary to confirm that the method is suitable for its intended purpose and complies with regulatory requirements. For bioanalytical methods, validation typically includes several key parameters:
-
Accuracy and Precision: Ensuring the method provides correct and consistent results.
-
Sensitivity: The ability to detect low concentrations of the analyte.
-
Selectivity: The method's ability to distinguish the analyte from other compounds in the matrix.
-
Recovery: The efficiency with which the analyte is extracted from the biological sample.
-
Stability: The analyte’s stability under different storage and handling conditions.
-
Linearity: The method’s ability to produce results that are directly proportional to the analyte concentration over a specified range.
Blank Biological Matrix and Blank Matrix play critical roles in this validation process. These control samples, which do not contain the analyte of interest, are essential for identifying potential matrix effects or interferences during the analysis. They help establish baseline levels for the analytes and ensure that the matrix itself does not contribute to signal contamination or suppression. Similarly, the use of drug-free matrices is crucial for validating that no residual drugs or metabolites are present in the sample that could skew the results.
Bioanalysis of Ophthalmic Medications
The wall of the eyeball is divided into three layers, the outer layer is the fibrous membrane; the middle membrane is the pigment membrane, vascular membrane or uvea; and the inner membrane is the retina. The eyeball is divided into two parts, the anterior and posterior regions of the eye, bounded by the back of the lens.
Figure 1. Anatomy of Human eye. (Seyedpour et al., 2023)
The major structures involved in drug metabolism include:
-
Cornea – The primary site for topical drug absorption, containing esterases and cytochrome P450 (CYP) enzymes that metabolize prodrugs like loteprednol etabonate.
-
Conjunctiva – Rich in drug-metabolizing enzymes (e.g., esterases and CYPs), contributing to first-pass metabolism before systemic absorption.
-
Aqueous Humor – Limited metabolic activity but plays a role in drug distribution and clearance.
-
Vitreous- Intravitreal injection can act directly on the retina and reduce toxicity in the somatic circulation. Small molecule drugs diffuse quickly, and large molecule drugs have a longer half-life. Vitreous changes with age affect pharmacokinetics.
-
Sclera-Sclera is more permeable to large molecule drugs and drug passage through the sclera is mainly affected by molecular size. Subconjunctival injections allow drugs to enter the choroid, but the process is complicated. Scleral melanin binds the drug and affects its release and duration of action.
-
Posterior eye region- The retroocular tissues are rich in blood flow and drugs can be eliminated via the body circulation or lymph. Choroidal vascular hyperpermeability allows drugs to easily enter the outer space, but it is difficult to cross the retinal pigment epithelium, which affects efficacy and leads to loss. Melanin-binding drugs can prolong the duration of action.
Aqueous Humor and Vitreous Humor
The aqueous humor and vitreous humor are essential ocular fluids that play critical roles in maintaining intraocular pressure, providing nutrients, and facilitating optical clarity. The aqueous humor is the thin, clear, watery fluid that fills both the anterior and posterior chambers of the eye, containing ions, proteins, carbohydrates, and oxygen. Most of the aqueous humor produced by the ciliary body, exits the eye at the angle formed by the junction of the iris and cornea. These fluids vary across species, including humans, monkeys, rabbits, and other non-human primates. They usually collected with large lot sizes from individual animals or pools.
Aqueous Humor Across Species
Human Aqueous Humor
The human aqueous humor is a clear, nutrient-rich fluid that maintains intraocular pressure and supports metabolic functions of the cornea and lens. It is produced by the ciliary body and flows through the anterior chamber before draining via the trabecular meshwork.
Monkey Aqueous Humor
The monkey aqueous humor closely resembles that of humans in composition and dynamics. Given the anatomical similarities between primates and humans, non-human primate aqueous humor serves as an essential reference for ophthalmic studies.
Rabbit Aqueous Humor
The rabbit aqueous humor differs significantly from that of primates, particularly in its protein concentration and rate of turnover. Rabbits are commonly used in ocular research, though species-specific variations must be considered.
Vitreous Humor Across Species
Human Vitreous Humor
The human vitreous humor is a gel-like substance composed primarily of water, collagen, and hyaluronic acid. It maintains ocular shape, absorbs shocks, and serves as a conduit for nutrient transport.
Monkey Vitreous Humor
The monkey vitreous humor shares a similar composition to human vitreous humor, making non-human primate vitreous humor an invaluable model for studying age-related vitreous degeneration and related pathologies.
Rabbit Vitreous Humor
The rabbit vitreous humor is structurally different, being more liquid-like and having lower collagen density. These differences influence its response to surgical interventions and pharmacological treatments.
Development of Artificial and Simulated Ocular Fluids
Artificial Aqueous and Artificial Aqueous Vitreous Humor
Artificial aqueous humor and artificial vitreous humor are engineered substitutes designed for use in ophthalmic surgeries, drug delivery, and research applications. These synthetic fluids mimic the biochemical and physical properties of their natural counterparts.
Simulated Aqueous and Simulated Vitreous Humor
Simulated aqueous humor and simulated vitreous humor are laboratory-prepared solutions used for in vitro experimentation and modeling ocular physiology. They facilitate controlled studies without the ethical constraints associated with animal or human samples.
Conclusion
The use of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) in bioanalysis represents a crucial advancement in analytical techniques for detecting and quantifying biological compounds, including drugs and metabolites in biological matrices. The method's high sensitivity, precision, and selectivity make it invaluable in both exogenous and endogenous substance analysis, especially in ophthalmic drug development. The detailed understanding of ocular anatomy and the role of fluids such as the aqueous and vitreous humor highlights the importance of these body components in drug delivery systems. Moreover, the development of artificial and simulated ocular fluids furthers research possibilities while ensuring ethical considerations are met. As analytical method validation continues to evolve, it ensures the reliability and reproducibility necessary for effective clinical applications, particularly in ophthalmology.
Keywords: LC-MS/MS, Blank Biological Matrix, Blank Matrix, Drug-free Matrix, Biofluids, Bioanalysis, Biological Analysis, Validation of Analytical, Analytical Method Validation, Analytical Method Development, Human Aqueous Humor; Monkey Aqueous Humor; Rabbit Aqueous Humor; Non-human Primate Aqueous Humor, Human Vitreous Humor; Monkey Vitreous Humor, Rabbit Vitreous Humor, Non-human Primate Vitreous Humor, Simulated Aqueous Humor, Simulated Vitreous Humor, Artificial Aqueous Humor, Artificial Vitreous Humor
Reference
Seyedpour, S. M., Lambers, L., Rezazadeh, G., & Ricken, T. (2023). Mathematical modelling of the dynamic response of an implantable enhanced capacitive glaucoma pressure sensor. Measurement: Sensors, 30, 100936. https://doi.org/10.1016/j.measen.2023.100936